Rickettsia parkeri
Rickettsia parkeri is a species of bacterium in the genus Rickettsia. It is a member of the spotted fever group (SFG) of rickettsiae, which are known to cause spotted fever illnesses in humans. This bacterium was first identified in 1939 in the United States and has since been recognized as a human pathogen.
Taxonomy and Classification[edit | edit source]
Rickettsia parkeri belongs to the family Rickettsiaceae, order Rickettsiales, class Alphaproteobacteria, and phylum Proteobacteria. It is closely related to other members of the spotted fever group, such as Rickettsia rickettsii, the causative agent of Rocky Mountain spotted fever.
Morphology and Genetics[edit | edit source]
Rickettsia parkeri is a small, obligate intracellular bacterium. It has a gram-negative cell wall structure and is typically rod-shaped. The genome of Rickettsia parkeri has been sequenced, revealing genes that are involved in its pathogenicity and intracellular survival.
Epidemiology[edit | edit source]
Rickettsia parkeri is primarily transmitted to humans through the bite of infected ticks. The primary vector in the United States is the Gulf Coast tick (Amblyomma maculatum). Cases of Rickettsia parkeri rickettsiosis have been reported in various regions, including the southeastern and south-central United States, as well as parts of South America.
Clinical Manifestations[edit | edit source]
Infection with Rickettsia parkeri, known as Rickettsia parkeri rickettsiosis, typically presents with mild to moderate symptoms. Common clinical features include fever, headache, rash, and an eschar at the site of the tick bite. The illness is generally less severe than Rocky Mountain spotted fever.
Diagnosis[edit | edit source]
Diagnosis of Rickettsia parkeri infection is based on clinical presentation, history of tick exposure, and laboratory testing. Polymerase chain reaction (PCR) and serological tests are commonly used to detect the presence of Rickettsia parkeri DNA or antibodies in patient samples.
Treatment[edit | edit source]
The treatment of choice for Rickettsia parkeri rickettsiosis is doxycycline, an antibiotic that is effective against rickettsial infections. Early treatment is important to prevent complications and ensure a favorable outcome.
Prevention[edit | edit source]
Preventive measures include avoiding tick-infested areas, using tick repellents, wearing protective clothing, and performing regular tick checks after potential exposure. Prompt removal of attached ticks can also reduce the risk of infection.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD